Recon: Novartis plans thousands of job cuts in global restructuring; FDA lifts hold on Gilead blood cancer trials
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy